Derailing individualized ovarian stimulation. - Wikidata - awgldk - TriplyDB

Derailing individualized ovarian stimulation.

Derailing individualized ovarian stimulation.

http://www.wikidata.org/entity/Q55304914

about

Derailing individualized ovarian stimulation.

http://www.wikidata.org/entity/Q55304914

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Derailing individualized ovarian stimulation.

@en

Derailing individualized ovarian stimulation.

@nl

type

label

Derailing individualized ovarian stimulation.

@en

Derailing individualized ovarian stimulation.

@nl

prefLabel

Derailing individualized ovarian stimulation.

@en

Derailing individualized ovarian stimulation.

@nl

P1433

Q55304914-CD7DF1AC-869F-4584-8B98-E4F2AE4133D4

P1476

Q55304914-9F7DC3DE-B610-4EAC-956F-645AD7EA254A

P2093

Q55304914-3D756619-A01F-4EAC-914C-262FF9623DEE

Q55304914-79275E0D-4A9F-4FB1-83C2-BE6241C005D2

P2860

Q55304914-16193F4C-9C5B-44EB-A470-B1FFE16FE545

Q55304914-7FACCA89-DC90-41E2-80A1-937ECFCDE016

Q55304914-9DD19C01-9348-452E-938D-5EFEFDC48F9C

Q55304914-F64B33F2-BE1E-47E3-BC54-9754A2702FC3

Q55304914-F8151DE2-1F0B-468B-83BD-A98090BC87DE

P304

Q55304914-3395CFE2-A405-48D4-BF6F-AB2F67AC8E27

P31

Q55304914-3919812C-3C14-4F63-9C61-7141EF9E4F98

P356

Q55304914-B3077869-DC70-4DD3-A93D-D205F1F5BB19

P407

Q55304914-2AE11F34-9F49-4B27-BB4D-8D1DE476FE0C

P433

Q55304914-DD9B58AE-68E7-46C7-8F8C-4DD9B38AC752

P478

Q55304914-32F24881-A65F-44ED-AB9D-D5D05C66F031

P577

Q55304914-3BB80993-603E-493F-9F97-A63F108D28FB

P698

Q55304914-AB1D3AA4-F8AA-480A-AD88-3825200CF607

P932

Q55304914-C0085391-D86F-4F11-9516-9E06250FD824

P356

P1433

Human Reproduction

P1476

Derailing individualized ovarian stimulation.

@en

P2093

Richard A Anderson

http://www.w3.org/2001/XMLSchema#string

Scott M Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women

Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.

Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

P304

980-981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEY060

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29596619

http://www.w3.org/2001/XMLSchema#string

P932

5925764

http://www.w3.org/2001/XMLSchema#string